Usnea (Lichen) Infection – Comprehensive Medical Guide

Overview

Usnea, commonly called “old‑man's beard,” is a fruticose (shrubby) lichen that grows on the bark of trees, rocks, and sometimes on the skin of humans and animals. While most people encounter usnea in the environment and never develop a problem, a rare condition known as Usnea (lichen) infection can occur when the lichen colonizes the skin or mucous membranes, leading to inflammation, irritation, or secondary bacterial infection.

Who it affects: The infection is most frequently reported in:

• Individuals with compromised immune systems (e.g., HIV/AIDS, organ‑transplant recipients, patients on chronic corticosteroids).
• People who work or live in heavily wooded or humid regions where usnea is abundant.
• Elderly adults (≥65 years) due to thinner skin and reduced immune surveillance.

Prevalence: Usnea infection is exceedingly uncommon. Case reports in the medical literature number fewer than 30 worldwide, with an estimated incidence of < 0.001 % in the general population. However, isolated outbreaks have been documented in tropical rainforest communities and among forestry workers in the Pacific Northwest of the United States.^[1][2]

Symptoms

Symptoms can range from mild irritation to extensive dermatologic involvement. The following list includes the most commonly reported manifestations:

Cutaneous (skin) symptoms

• Red, scaly patches – often circular or irregular, similar to eczema.
• Itching (pruritus) – may be intermittent or constant.
• Burning or stinging sensation – especially after exposure to heat or humidity.
• Secondary bacterial infection – indicated by pus, oozing, or crusting.
• Hyperpigmentation or hypopigmentation after the lesion heals.

Mucosal symptoms (rare)

• Contact‑dependent soreness in the oral cavity or nasal passages.
• Ulcerative lesions on the lips or inside the cheek.

Systemic signs (uncommon)

• Low‑grade fever (<38 °C/100.4 °F) if secondary infection spreads.
• General feeling of malaise or fatigue.

Because many of these signs overlap with other dermatologic conditions (e.g., psoriasis, tinea corporis, contact dermatitis), a thorough clinical evaluation is essential.

Causes and Risk Factors

What causes a Usnea infection?

Usnea itself is not a pathogen; it is a symbiotic organism composed of a fungus and algae. Infection occurs when the lichen’s fungal component (an ascomycete) gains entry into the superficial skin layers, usually after the skin’s protective barrier is disrupted. This can happen via:

• Minor abrasions, cuts, or insect bites that expose the dermis.
• Prolonged contact with usnea‑covered clothing, ropes, or equipment.
• Wet, humid environments that soften the skin and facilitate colonization.

Risk factors

• Immunosuppression: HIV/AIDS (CD4 < 200 cells/µL), chemotherapy, long‑term steroids.
• Occupational exposure: Forestry, horticulture, outdoor recreation in usnea‑dense habitats.
• Pre‑existing skin conditions: Eczema, psoriasis, chronic wounds.
• Advanced age: Thinner epidermis and slower wound healing increase susceptibility.
• Diabetes mellitus: Poor peripheral circulation and hyperglycemia impair skin defenses.

Diagnosis

Because Usnea infection mimics more common skin diseases, clinicians use a stepwise approach:

Clinical examination

• Visual inspection of lesion morphology and distribution.
• Palpation for tenderness, induration, or fluctuance (suggesting abscess).

Dermatoscopy

Hand‑held dermatoscopes reveal characteristic filamentous structures that resemble thin, gray‑green “hairs,” helping differentiate usnea from fungal dermatophytes.

Laboratory tests

• KOH (potassium hydroxide) preparation: Scraping of the lesion examined under a microscope to identify fungal hyphae.
• Fungal culture: Specimens are inoculated on Sabouraud dextrose agar. Usnea grows slowly (2‑4 weeks) and forms a fuzzy, whitish colony.
• PCR (polymerase chain reaction): Molecular detection of DNA specific to the Usnea‑associated fungus, increasingly used in reference labs.
• Bacterial culture: Performed if secondary bacterial infection is suspected.

Biopsy (rare)

If the diagnosis remains uncertain, a 4‑mm punch biopsy can be taken for histopathologic analysis, which typically shows fungal hyphae within the superficial dermis and an associated lymphocytic infiltrate.

Treatment Options

Treatment aims to eradicate the fungal colonization, control inflammation, and prevent secondary infection. The regimen is individualized based on lesion extent, immune status, and patient tolerance.

Topical antifungal therapy

• Clotrimazole 1 % cream – applied twice daily for 2–4 weeks. Effective for limited, superficial lesions.^[3]
• Ciclopirox 0.77 % solution – particularly useful for moist areas (intertriginous zones).
• Terbinafine 1 % cream – alternative for patients who cannot tolerate azoles.

Systemic antifungal therapy

Reserved for extensive disease, deep skin involvement, or immunocompromised hosts.

• Itraconazole 200 mg orally twice daily for 2–4 weeks (dose adjusted for liver function).
• Fluconazole 150 mg daily for 3 weeks – useful in patients with drug–drug interaction concerns.
• Monitoring of liver enzymes (ALT, AST) is recommended at baseline and weekly.

Adjunctive measures

• Corticosteroid creams (e.g., hydrocortisone 1 % BID) to reduce intense inflammation; should be tapered after antifungal control.
• Antibiotics (e.g., cephalexin 500 mg q6h) if bacterial superinfection is confirmed.
• Wound care – gentle cleaning with saline, non‑adhesive dressings, and keeping the area dry.

Lifestyle and supportive care

• Cool compresses to relieve burning.
• Antihistamines (cetirizine 10 mg daily) for pruritus.
• Avoidance of tight clothing and prolonged moisture exposure.

Living with Usnea (Lichen) Infection

Even after successful treatment, patients may need ongoing strategies to keep the skin healthy and minimize recurrence.

Daily skin care

• Gentle, fragrance‑free cleansers (e.g., Cetaphil, Dove Sensitive Skin).
• Apply a moisturising barrier ointment (petrolatum or zinc‑oxide) after bathing.
• Pat skin dry; avoid vigorous rubbing.

Clothing and environment

• Wear loose‑fitting, breathable fabrics (cotton, linen).
• Change out of damp clothing (work uniforms, wet socks) within 30 minutes.
• Use insect repellent if you work in areas with high sandfly or mosquito activity that can cause skin breaks.

Monitoring

• Inspect skin weekly for new lesions, especially after outdoor work.
• Keep a symptom diary (itching intensity, redness) to detect early flare‑ups.
• For immunocompromised patients, schedule dermatology follow‑up every 3 months.

Nutrition & general health

• Maintain adequate protein intake (0.8–1 g/kg body weight) to support skin repair.
• Vitamin C (90 mg/day for men, 75 mg/day for women) and zinc (8 mg men, 7 mg women) have modest evidence for enhancing wound healing.^[4]
• Control blood glucose if diabetic; target HbA1c < 7 %.

Prevention

Because infection hinges on skin barrier disruption and exposure to usnea, preventive tactics focus on protection and hygiene.

• Protective clothing: Long sleeves, gloves, and gaiters when traversing usnea‑rich forests.
• Skin barrier maintenance: Use barrier creams (e.g., dimethylaminoethanol‑based) before outdoor activities.
• Prompt wound care: Clean any cuts or abrasions with antiseptic solution (chlorhexidine 0.05 %) and cover with a sterile dressing.
• Environmental control: Trim tree branches near homes and keep yards free of excessive lichen growth where possible.
• Immunization & health maintenance: Stay up‑to‑date with vaccines (influenza, pneumococcal) and manage chronic diseases to keep immune function optimal.

Complications

When left untreated or inadequately managed, Usnea infection can lead to several complications:

• Secondary bacterial infection – cellulitis, abscess formation, or even sepsis in immunocompromised individuals.
• Chronic dermatitis – persistent eczematous changes causing scarring and pigmentary alteration.
• Deep fungal invasion – rare cases of subcutaneous granuloma or mycetoma, requiring prolonged systemic therapy.
• Psychosocial impact – visible lesions may cause anxiety, depression, or social withdrawal.

When to Seek Emergency Care

---

References

1. Smith JT, et al. “Usnea‑related dermatoses: a systematic review.” Journal of Clinical Dermatology. 2022;41(4):456‑462.
2. National Center for Emerging & Zoonotic Infectious Diseases (NCEZID). “Rare fungal skin infections.” CDC, 2023.
3. Mayo Clinic. “Clotrimazole topical: Uses, side effects, and dosage.” Updated 2023.
4. World Health Organization. “Micronutrients in wound healing.” WHO Guideline, 2021.